Advanced Medical Solutions Group PLC

Advanced Medical Solutions Group PLC

Health CareHealth Care Equipment & Services
  • Price (GBX)325.50
  • Today's Change0.50 / 0.15%
  • Shares traded60.65k
  • 1 Year change52.10%
  • Beta0.3507
Data delayed at least 20 minutes, as of Feb 23 2018 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Advanced Medical Solutions Group PLC grew revenues 20.45% from 68.60m to 82.62m while net income improved 11.14% from 14.12m to 15.69m.
Gross margin58.66%
Net profit margin19.54%
Operating margin24.06%
Return on assets12.08%
Return on equity13.75%
Return on investment13.36%
More ▼

Cash flow in GBPView more

In 2016, Advanced Medical Solutions Group PLC increased its cash reserves by 49.48%, or 16.92m. The company earned 19.83m from its operations for a Cash Flow Margin of 24.00%. In addition the company used 2.43m on investing activities and also paid 1.03m in financing cash flows.
Cash flow per share0.0957
Price/Cash flow per share33.92
Book value per share0.6553
Tangible book value per share0.3935
More ▼

Balance sheet in GBPView more

Advanced Medical Solutions Group PLC has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 51.13m.
Current ratio6.00
Quick ratio5.20
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in GBP

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 15.00% and 10.44%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Biotechnology & Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
Div yield(5 year avg)0.01%
Div growth rate (5 year)15.38%
Payout ratio (TTM)7.48%
EPS growth(5 years)19.41
EPS (TTM) vs
TTM 1 year ago
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.